Measles virus-specific IgG-antibodies level in umbilical cord blood according to the maternal age


Cite item

Full Text

Abstract

Introduction. Mass vaccination and re-vaccination against measles as of children, as well additionally in adults, contributed to the significant decrease in morbidity rate. At the same time, outbreaks of measles in recent years, both in the World and in Russia, became more frequent, especially in the adult population. Aim: To determine the content of transplacental IgG-antibodies to measles virus in the umbilical cord blood, with taking into account of the age of the mother. Materials and methods. There was studied the cord blood of offsprings of 672 parturient women aged 16-43 years old, residing in Moscow and Moscow region, without a history of measles previously. The level of IgG-antibodies was determined by ELISA with the use of a standard set of reagents of the Firm "VECTOR-BEST", accordingly to instructions. Results. Protective (0.18 IU/ml) IgG-antibodies to measles virus in neonates were recorded in 79.9%. In females aged of 16-20 years protective antibodies were detected in 89,7%, 21-25 years - 80,8%, 26-30 years - 75% 31-35 - 75% 36-43 - 88,2% of cases. Average protective antibody level decreased according to the maternal age, respectively, and was the lowest (1,34 ± 0 22 IU/ml) in the group of women aged of 26 to 30 years and the high level was noted in 16-20 and 36-43 years old cases (2,18 ± 0,47 IU/ml and 2,73 ± 0,44 IU/ml). Conclusion. Women aged of 26-30 years are at risk for the development of measles infection, which is an indication for vaccination before pregnancy.

About the authors

M. P Kostinov

Mechnikov Institute of Vaccines and Sera

Email: vaccine@bk.ru
доктор мед. наук, проф., засл. деятель науки РФ, зав. лаб. вакцинопро-филактики и иммунотерапии аллергических заболеваний

A. D Shmitko

Mechnikov Institute of Vaccines and Sera

Email: violadellanna@gmail.com
аспирант, мл. науч. сотр. лаб. вакцинопрофилактики и иммунотерапии аллергических заболеваний

I. I Bocharova

Moscow Regional Scientific Research Institute of Obstetrics and Gynecology

Email: 567891@mail.ru
доктор мед. наук, вед. специалист

A. P Cherdancev

Ulyanovsk State University

Email: sas@mv.ru
канд, мед. наук, доцент каф. педиатрии

A. A Savisko

Rostov State Medical University

Email: annsav@mail.ru
канд. мед. наук, доцент каф. пропедевтики детских болезней

V. B Polishchuk

Mechnikov Institute of Vaccines and Sera

Email: vaccine@bk.ru
канд. мед. наук, ст. науч. сотр. лаб. вакци-нопрофилактики и иммунотерапии аллергических заболеваний

References

  1. Зверев В.В., Юминова Н. В. Вакцинопрофилактика вирусных инфекций от Э. Дженнера до настоящего времени. Вопросы вирусологии. 2012; Прил. 1: 33-42.
  2. WHO (2011). Measles outbreaks: Regions of the Americas, Europe and Africa. Global Alert and Response (GAR). World Health Organization 2011. Available at: http://www.who.int/csr/ don/2011_10_07/en/index.html
  3. WHO (2013). Progress in global control and regional elimination of measles, 2000-2011. Weekly epidemiological record. 2013; 3 (88): 29-36. Available at: http://www.who.int/wer/2013/ wer8803.pdf
  4. Онищенко Г.Г. Инфекционная заболеваемость в Российской Федерации за январь-октябрь 2012. Медицинский алфавит. Эпидемиология и гигиена. 2012; 4: 3-4.
  5. Соловьева И.Л., Костинов М.П., Кусельман А.И. Особенности вакцинации детей с измененным преморбидным фоном против гепатита В, кори, эпидемического паротита. Ульяновск: УлГУ; 2006.
  6. Таточенко В.К., Озерецковский Н.А., Федоров А.М. Иммунопрофилактика - 2011 (справочник). М.: Издательство Союза педиаторов России; 2011.
  7. Anselem O., Tsatsaris V., Lopez E., Krivine A., Le Ray C., Loulergue P. et al. Measles and pregnancy. PresseMed. 2011; 40 (11): 1001-7.
  8. Chiba M.E., Saito M., Suzuki N., Honda Y., Yaegashi N. Measles infection in pregnancy. J. Infect. 2003; 47 (1): 40-4.
  9. Enders M., Biber M., Exler S. Measles, mumps and rubella virus infection in pregnancy. Possible adverse effects on pregnant women, pregnancy outcome and the fetus. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007; 50 (11): 1393-8.
  10. Guillet M., Vauloup-Fellous C., Cordier A.G., Grangeot-Keros L., Benoist G., Nedellec S. et al. Measles in pregnancy: a review. J. Gynecol. Obstet. Biol. Reprod. (Paris). 2012; 41 (3):209-18.
  11. White S.J., Boldt K.L., Holditch S.J., Poland G.A., Jacobson R.M. Measles, mumps, and rubella. Clin. Obstet. Gynecol. 2012; 55 (2): 550-9.
  12. Gans H., DeHovitz R., Forghani B., Beeler J., Maldonado Y., Arvin A.M. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine. 2003; 21 (24): 3398-405.
  13. Plans P., Costa J., Dominguez A., Torner N., Borras E., Plasencia A. Prevalence of protective measles virus antibody levels in umbilical cord blood samples in Catalonia, Spain. Clin. Vac. Immunol. 2010; 17 (4): 691-4.

Copyright (c) 2014 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies